U-BX TECHNOLOGY-A (UBXG) Fundamental Analysis & Valuation

NASDAQ:UBXGKYG9161K1123

Current stock price

3.34 USD
+1.77 (+112.63%)
At close:
2.3 USD
-1.04 (-31.14%)
After Hours:

This UBXG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. UBXG Profitability Analysis

1.1 Basic Checks

  • In the past year UBXG has reported negative net income.
  • UBXG had a negative operating cash flow in the past year.
  • In the past 5 years UBXG reported 4 times negative net income.
  • The reported operating cash flow has been mixed in the past 5 years: UBXG reported negative operating cash flow in multiple years.
UBXG Yearly Net Income VS EBIT VS OCF VS FCFUBXG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -2M -4M -6M -8M

1.2 Ratios

  • With a Return On Assets value of -11.31%, UBXG is not doing good in the industry: 70.45% of the companies in the same industry are doing better.
  • UBXG has a worse Return On Equity (-12.47%) than 60.23% of its industry peers.
Industry RankSector Rank
ROA -11.31%
ROE -12.47%
ROIC N/A
ROA(3y)-4.39%
ROA(5y)-2.76%
ROE(3y)-0.16%
ROE(5y)-3.71%
ROIC(3y)N/A
ROIC(5y)N/A
UBXG Yearly ROA, ROE, ROICUBXG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • With a Gross Margin value of 0.98%, UBXG is not doing good in the industry: 92.05% of the companies in the same industry are doing better.
  • UBXG's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for UBXG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 0.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5Y16.68%
UBXG Yearly Profit, Operating, Gross MarginsUBXG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8 -10

6

2. UBXG Health Analysis

2.1 Basic Checks

  • UBXG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for UBXG has been increased compared to 1 year ago.
  • Compared to 5 years ago, UBXG has more shares outstanding
  • UBXG has a better debt/assets ratio than last year.
UBXG Yearly Shares OutstandingUBXG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
UBXG Yearly Total Debt VS Total AssetsUBXG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • UBXG has an Altman-Z score of 16.79. This indicates that UBXG is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 16.79, UBXG belongs to the best of the industry, outperforming 97.73% of the companies in the same industry.
  • UBXG has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • UBXG's Debt to Equity ratio of 0.02 is fine compared to the rest of the industry. UBXG outperforms 78.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 16.79
ROIC/WACCN/A
WACC7.77%
UBXG Yearly LT Debt VS Equity VS FCFUBXG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

2.3 Liquidity

  • A Current Ratio of 10.24 indicates that UBXG has no problem at all paying its short term obligations.
  • UBXG has a better Current ratio (10.24) than 97.73% of its industry peers.
  • A Quick Ratio of 10.24 indicates that UBXG has no problem at all paying its short term obligations.
  • UBXG has a better Quick ratio (10.24) than 97.73% of its industry peers.
Industry RankSector Rank
Current Ratio 10.24
Quick Ratio 10.24
UBXG Yearly Current Assets VS Current LiabilitesUBXG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

0

3. UBXG Growth Analysis

3.1 Past

  • UBXG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 68.46%, which is quite impressive.
  • The Revenue for UBXG has decreased by -41.94% in the past year. This is quite bad
  • UBXG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -13.58% yearly.
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.42%
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-30.04%
Revenue growth 5Y-13.58%
Sales Q2Q%-42.49%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
UBXG Yearly Revenue VS EstimatesUBXG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

0

4. UBXG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for UBXG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UBXG Price Earnings VS Forward Price EarningsUBXG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
UBXG Per share dataUBXG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. UBXG Dividend Analysis

5.1 Amount

  • UBXG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

UBXG Fundamentals: All Metrics, Ratios and Statistics

U-BX TECHNOLOGY-A

NASDAQ:UBXG (3/31/2026, 7:14:39 PM)

After market: 2.3 -1.04 (-31.14%)

3.34

+1.77 (+112.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.58%
Inst Owner ChangeN/A
Ins Owners34.17%
Ins Owner ChangeN/A
Market Cap101.14M
Revenue(TTM)46.96M
Net Income(TTM)-2.37M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio14.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.15
P/FCF N/A
P/OCF N/A
P/B 5.32
P/tB 5.32
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.28
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS1.55
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.31%
ROE -12.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 0.98%
FCFM N/A
ROA(3y)-4.39%
ROA(5y)-2.76%
ROE(3y)-0.16%
ROE(5y)-3.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.64%
GM growth 5Y16.68%
F-Score2
Asset Turnover2.24
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49007.6%
Cap/Sales 12.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.24
Quick Ratio 10.24
Altman-Z 16.79
F-Score2
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)16439.3%
Cap/Depr(5y)9922.48%
Cap/Sales(3y)6.51%
Cap/Sales(5y)3.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.46%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.94%
Revenue growth 3Y-30.04%
Revenue growth 5Y-13.58%
Sales Q2Q%-42.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-215.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-529.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-108.48%
OCF growth 3YN/A
OCF growth 5YN/A

U-BX TECHNOLOGY-A / UBXG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of U-BX TECHNOLOGY-A (UBXG) stock?

ChartMill assigns a fundamental rating of 2 / 10 to UBXG.


Can you provide the valuation status for U-BX TECHNOLOGY-A?

ChartMill assigns a valuation rating of 0 / 10 to U-BX TECHNOLOGY-A (UBXG). This can be considered as Overvalued.


Can you provide the profitability details for U-BX TECHNOLOGY-A?

U-BX TECHNOLOGY-A (UBXG) has a profitability rating of 1 / 10.